Somewhat surprisingly, given that CML cell lines responded to Src inhibition in vitro (67–71), Lyn, Hck, and Fgr were not required to induce CML in vivo (47). Here, SRC is linked to chronic myelogenous leukemia, BCR-ABL1 positive.